Why this matters: ORCL is now down 17% on the week and 21% on the month. Three independent data streams — options positioning, short interest, and borrowing cost — are moving in the same direction simultaneously. That convergence is new. Prior reports noted the lending market was "not the story." It is now.
Options: The put/call ratio has held above 1.0 for four consecutive sessions. It sat at 1.014 on June 25, against a 20-day mean of 0.933. That's 1.7 standard deviations above the norm — and the sustained elevation matters more than any single day's reading. The 52-week high is 1.06. Options traders are as defensive as they've been all year.
Short interest: SI hit 1.41% of free float on June 25. That's up 12.4% in one week and 25% over the past month. In absolute terms, short sellers added roughly 5.3 million shares in a single week. The 1-day change alone was 8.5%. Short positions are being built quickly, not gradually.
Cost to borrow: The CTB pulse flagged a doubling to 0.40% in one week. The current reading is 0.36% — still roughly double the ~0.20% seen on June 17. Borrow costs have repriced sharply upward even as availability remains extremely loose at 3,573%. Demand for borrows is rising faster than supply is tightening. That's a demand-side story.
The backdrop is not subtle. The June 10 earnings print sent ORCL down 10.5% in a single session. The $184 floor, which held for two weeks, broke last week. The stock closed at $152.46 on June 25 — roughly 30% below pre-earnings levels.
Analysts remain broadly constructive. The consensus is "buy," with 28 buy ratings. Bernstein raised its target to $325 post-earnings. Barclays went to $250. Guggenheim holds at $400. But Wedbush cut to $240 from $275, and Stephens holds an Equal-Weight at $164 — almost exactly where the stock is trading. The Street's average target is well above current prices, but the market has now spent three weeks declining to close that gap.
The ORTEX short score sits at 30.6, near the low end of the range, reflecting that SI as a share of float is still modest. The borrowing pool is vast — over 1 billion shares available. A squeeze is not the story here. The story is directional: short sellers are adding positions, put buyers are adding hedges, and borrow costs are rising. All three are moving the same way, for the same reason.
The EPS momentum factor score stands at 97th percentile — reflecting strong analyst estimate revisions. That creates the central contradiction: fundamental analysts are revising earnings estimates upward while the market sells the stock down.
See the live data behind this article on ORTEX.
Open ORCL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
